Chemoinformaics analysis of Furo[2,3-f]chromen-7-one
| Molecular Weight | 186.166 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 23 |
| Exact Molecular Weight | 186.032 | nRing | 3 |
| Solubility: LogS | -3.141 | nHRing | 2 |
| Solubility: LogP | 6.596 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 24.7768 |
| nHD | 0 | BPOL | 10.3592 |
| QED | 0.643 |
| Synth | 3.754 |
| Natural Product Likeliness | 2.726 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.923 |
| Pgp-sub | 0.003 |
| HIA | 0.009 |
| CACO-2 | -4.843 |
| MDCK | 0.00002 |
| BBB | 0.046 |
| PPB | 1.00471 |
| VDSS | 4.293 |
| FU | 0.0160206 |
| CYP1A2-inh | 0.744 |
| CYP1A2-sub | 0.679 |
| CYP2c19-inh | 0.957 |
| CYP2c19-sub | 0.262 |
| CYP2c9-inh | 0.874 |
| CYP2c9-sub | 0.968 |
| CYP2d6-inh | 0.877 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.708 |
| CYP3a4-sub | 0.502 |
| CL | 11.443 |
| T12 | 0.208 |
| hERG | 0.615 |
| Ames | 0.013 |
| ROA | 0.472 |
| SkinSen | 0.931 |
| Carcinogencity | 0.357 |
| EI | 0.035 |
| Respiratory | 0.799 |
| NR-Aromatase | 0.906 |
| Antiviral | No |
| Prediction | 0.593953 |